RetinalGenix Reports Near-Zero Cash, Critical Liquidity Crisis, and Going Concern Doubts
summarizeSummary
RetinalGenix Technologies Inc. is facing an extreme liquidity crisis with only $180 in cash as of March 31, 2026, and a very limited runway despite a recent $200,000 capital raise, reinforcing significant going concern doubts.
check_boxKey Events
-
Critical Cash Shortage
The company reported a cash balance of only $180 as of March 31, 2026, down from $14,774 at December 31, 2025. This indicates an immediate and severe liquidity crisis.
-
Substantial Doubt About Going Concern
Management explicitly stated that the company does not have adequate resources to fund operations beyond a few days from March 31, 2026, raising substantial doubt about its ability to continue as a going concern.
-
Limited Capital Raise
In May 2026, the company sold 88,888 shares of common stock at $2.25 per share, raising gross proceeds of $200,000. This small capital infusion is expected to fund operations only through June 2026.
-
Material Weakness in Internal Controls
The company reiterated that its disclosure controls and procedures were ineffective as of March 31, 2026, due to a material weakness in internal control over financial reporting related to a lack of segregation of duties.
auto_awesomeAnalysis
RetinalGenix Technologies Inc. has reported an alarming cash balance of only $180 as of March 31, 2026, indicating an immediate and severe liquidity crisis. The company explicitly states it does not have adequate resources to fund operations beyond a few days from March 31, 2026. While a subsequent event in May 2026 saw the company raise $200,000 from a stock sale, this amount is a temporary measure that only extends the runway through June 2026. This dire financial situation reinforces the substantial doubt about the company's ability to continue as a going concern, a concern previously highlighted in its 10-K filing. The company also reiterated a material weakness in internal controls due to a lack of segregation of duties.
At the time of this filing, RTGN was trading at $4.00 on OTC in the Industrial Applications And Services sector, with a market capitalization of approximately $75M. The 52-week trading range was $0.25 to $20.00. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.